PillSense for Suspected Upper Gastrointestinal Bleeding

Last updated: December 5, 2024
Sponsor: Tan Tock Seng Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hemorrhage

Gastric Ulcers

Ulcers

Treatment

PillSense System

Clinical Study ID

NCT06500468
2024/00060
  • Ages 21-99
  • All Genders

Study Summary

This study aims to evaluate the efficacy and safety of a novel blood sensing capsule (PillSense), to help emergency doctors better evaluate if patients have active upper digestive tract bleeding, to determine if they can be discharged safely. The PillSense System consists of the PillSense Capsule, a small single use capsule that is safe for human consumption and PillSense Receiver, an external real-time monitor for data display to detect the presence of bleeding in the upper digestive tract within 10 minutes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Males or females aged 21 years and above and are able to give consent.

  • Patients who are willing and able to comply with the study protocol (includingundergoing endoscopy)

  • Presented to Emergency Department with symptoms of acute overt uppergastrointestinal bleeding such as coffee ground vomiting and melena (but withoutmelaena on physical examination)

Exclusion

Exclusion Criteria:

  • Patients who had hemodynamic shock (systolic blood pressure below 90 mm Hg and pulserate over 120/min)

  • Patients who presented with fresh hematemesis, hematochezia and/or melaena

  • Patients requiring urgent endoscopy / surgery at time of review or already plannedfor admission by ED physician for non UGIB related indications

  • Patients who had conditions that might contraindicate the use of an ingestiblecapsule, such as capsule endoscopy (eg. Dysphagia, odynophagia, swallowing disorder,and/or Zenker's diverticulum, issues with the motility of the gastrointestinaltract, Crohn's disease, previous GI surgery, suspected ileus, bowel obstructionand/or perforation)

  • Patients with a known history of oesophageal or gastric varices

  • Patients with known UGI pathology (such as oesophageal/gastric cancer), or recent (within 3 months) upper GI ulcer bleeding, upper GI surgeries or procedures

  • Patients who are on anticoagulation

  • Patients with cardiac implantable electrical device (CIED)

  • Patients who had altered mental status

  • Pregnant and/or lactating women (Female patients below age 60, without history ofhysterectomy or are not documented to be post-menopausal, will be given a urinepregnancy test to confirm they are not pregnant)

  • Patients who have an MRI investigation planned within 2 weeks

Study Design

Total Participants: 84
Treatment Group(s): 1
Primary Treatment: PillSense System
Phase:
Study Start date:
July 18, 2024
Estimated Completion Date:
January 31, 2026

Study Description

The use of the PillSense System enables the clinician to make a more informed choice on the treatment plan for the patient. If the system revealed "No Blood Detected", this is suggestive there is absence of blood in the stomach. Together with the presenting symptoms, physical examination and laboratory tests, it gives the emergency physician a more accurate method to detect if patient is actively bleeding. If patient remained stable during the monitoring, the patient can be discharged home for early outpatient review, instead of waiting in Emergency Department (ED) for prolonged duration to be admitted and wait in the ward for investigations like gastroscopy to be performed. This reduces unnecessary strain on the hospital's limited resources and may improve overall patient's experience. Patients with 'Blood Detected' result will be admitted with early gastroscopy planned within 72 hours. Patients with 'No Blood Detected' result, will be monitored closely in ED and, if deemed to be stable, to be discharged with an outpatient gastroscopy within 96 hours. A product such as the PillSense System which employs a minimally invasive method to help clinicians detect whether or not a patient has blood in upper gastrointestinal tract within 10 minutes. This will be a quick and objective tool to determine if the patient is having active upper gastrointestinal bleeding (UGIB), to assist in triaging patients for more emergent definitive care. This system can also be easily administered by non-clinician and do not require special training to read the results, minimising the need for highly specialised staff to provide this service. The information provided by the PillSense System which taken together with other clinical parameters may lead to more efficient, safer and higher quality patient care.

Connect with a study center

  • Tan Tock Seng Hospital

    Singapore,
    Singapore

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.